SMART BOMB DRUG: Federal health regulators approved an innovative breast cancer drug on Friday that targets tumor cells while sparing healthy ones.
PHARMA COCKTAIL: The drug Kadcyla from Roche combines the older drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.